Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review
Frontiers in Pharmacology · 24.09.2025 · 16
DOI: 10.3389/fphar.2025.1644907 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.09.2025. Verfasst von Rahul Mittal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, United States. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The growing limitations of animal models in drug testing and biomedical research, including ethical concerns, high costs, and poor translational relevance to human biology, have driven increasing interest in computational simulation models. These models encompass in silico approaches, pharmacokinetic/pharmacodynamic frameworks, molecular simulations, and organ-on-chip technologies, offering greater precision in replicating human physiological and pathological processes.
Methods
A systematic review was conducted to examine the role of computational simulation models as alternatives to traditional animal-based research. Relevant literature on their applications, predictive accuracy, translational value, and alignment with ethical research practices was analyzed.
Results
Computational models were found to bridge critical gaps in predictive accuracy and translational relevance, supporting drug development pipelines, reducing late-stage failures, and enhancing opportunities for personalized medicine. Additionally, their capacity to reduce reliance on animal models aligns with global ethical initiatives promoting humane and sustainable research practices.
Discussion
Simulation-based approaches represent a transformative opportunity for biomedical research. While their potential to reshape drug development and improve health outcomes is evident, challenges such as standardization, scalability, and regulatory integration remain. Addressing these barriers will be essential to fully realize the potential of computational simulation models in replacing or reducing animal testing and advancing human-centered biomedical innovation. Systematic Review Registration identifier, INPLASY2024110028.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, United States.
- Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, United States.
Zitieren
APA
Mittal, R., Ho, A., Adivikolanu, H., Sawhney, M., Lemos, J. R. N., Mittal, M., & Hirani, K. (2025). Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1644907
Vancouver
Mittal R, Ho A, Adivikolanu H, Sawhney M, Lemos JRN, Mittal M, et al. Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1644907
BibTeX
@article{Mittal2025,
author = {Mittal, Rahul and Ho, Alan and Adivikolanu, Harini and Sawhney, Muskaan and Lemos, Joana R N and Mittal, Mannat and Hirani, Khemraj},
title = {Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1644907}
}
EUVIMED